61R Stock Overview
Through its subsidiaries, designs, manufactures, and distributes medical equipment under the Euromedis brand name for healthcare professionals, local communities, and individuals in France and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Laboratoires Euromedis Société anonyme Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €4.42 |
| 52 Week High | €6.26 |
| 52 Week Low | €4.07 |
| Beta | -0.41 |
| 1 Month Change | -2.00% |
| 3 Month Change | -15.33% |
| 1 Year Change | -13.33% |
| 3 Year Change | -51.90% |
| 5 Year Change | n/a |
| Change since IPO | -79.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| 61R | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0.7% | -2.9% | -2.6% |
| 1Y | -13.3% | -8.5% | 6.9% |
Return vs Industry: 61R underperformed the German Medical Equipment industry which returned -8.5% over the past year.
Return vs Market: 61R underperformed the German Market which returned 6.9% over the past year.
Price Volatility
| 61R volatility | |
|---|---|
| 61R Average Weekly Movement | 3.5% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 61R has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 61R's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 190 | Mathieu Roturier | www.laboratoires-euromedis.fr |
Laboratoires Euromedis Société anonyme, through its subsidiaries, designs, manufactures, and distributes medical equipment under the Euromedis brand name for healthcare professionals, local communities, and individuals in France and internationally. It offers sterile or non-sterile medical gloves, dressings and compresses, medical sets, parenteral approach, needles, syringes, infusers, catheters, etc.; and wound drainage products, probes, and a draping range for operating theaters, as well as surgical gloves and protective covers. The company also provides oxygen therapy; incontinence and various hygiene-related products; a range of diagnostics; and a range of home care products.
Laboratoires Euromedis Société anonyme Fundamentals Summary
| 61R fundamental statistics | |
|---|---|
| Market cap | €12.65m |
| Earnings (TTM) | €18.15m |
| Revenue (TTM) | €31.01m |
0.7x
P/E Ratio0.4x
P/S RatioIs 61R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 61R income statement (TTM) | |
|---|---|
| Revenue | €31.01m |
| Cost of Revenue | €28.16m |
| Gross Profit | €2.85m |
| Other Expenses | -€15.29m |
| Earnings | €18.15m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.37 |
| Gross Margin | 9.20% |
| Net Profit Margin | 58.52% |
| Debt/Equity Ratio | 41.0% |
How did 61R perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:53 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Laboratoires Euromedis Société anonyme is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephanie Lefebvre | Gilbert Dupont |
| Romain Freismuth | Portzamparc BNP Paribas |